Morgan Stanley maintains EQT at Overweight, lowers price target to $66 from $67

Morgan Stanley kept its Overweight rating on EQT but reduced its price target to $66 from $67. The new target suggests a 31.1% upside from the Nov 17 close of $50.36. Recent analyst price targets for EQT range from $53 to $77.

Original reporting
Published Nov 18, 2026, 3:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 4:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley maintains EQT at Overweight, lowers price target to $66 from $67 — source image
Decision brief

The 30-second read

$EQTNeutralLow
01

Why it matters

For EQT, the actionable signal is limited because the rating stays Overweight and the target change is small; it mainly affects valuation expectations rather than near-term fundamentals.

02

Market read

Traders may treat this as a minor sentiment input rather than a standalone catalyst.

03

What to watch

The article does not provide the thesis behind the target change, so traders may need to check the underlying analyst note for drivers (commodity assumptions, balance-sheet outlook, or volume/cost estimates).

Relevance 4/10Novelty 3/10Timing: today’s analyst-note update, no scheduled company event cited

Background

The piece is an analyst rating maintenance update from Morgan Stanley, not a company disclosure.

Company-level read

Ticker impact

$EQTNeutralHigh confidence
Context

Morgan Stanley maintained EQT at Overweight and cut its price target to $66 from $67, signaling a modest valuation reset.

Expected impact

Likely mild downside bias as the market digests the lower target, though the unchanged Overweight rating should limit downside follow-through.

Evidence & confidence

The only disclosed change is a $1 reduction in the price target; no new fundamentals, guidance, or event risk is mentioned.

Market effects

Minimal, since this is a single-name analyst target adjustment with no sector-wide catalyst described.

None indicated; the note is company-specific.

None indicated; no cross-border or macro linkage is provided.

Counterpoint

The unchanged Overweight rating may matter more than the small target cut, implying the market may largely ignore the adjustment.

Key entities

  • EQT

    Subject of the analyst action: maintained Overweight, lowered price target to $66 from $67.

  • Morgan Stanley

    Issued the rating maintenance and price-target reduction referenced in the article.

Related articles

$EQTHighAI 9/10

October tacks on another $18 billion

U.S. upstream M&A deal value reached $12.6B in Q3, up from $11.5B in Q2. October saw $18B in deals, including EQT's $13.8B acquisition of Range Resources and Crescent Energy's $4.2B purchase from Devon Energy. 2023 deal value stands at $80.5B, exceeding 2022's total. Higher oil prices and international demand are driving activity, with the Permian and Eagle Ford basins being key areas of focus.

$EQTHighAI 8/10

How Did USA Upstream M&A Look in Q3 2026?

U.S. upstream M&A reached $12.6B in Q3 2026, up from $11.5B in Q2, with notable deals involving Magnolia, Matador, and others. October saw additional large transactions, including EQT's $13.8B acquisition of Range Resources. Total 2026 deal value is $80.5B, surpassing 2025's total. High oil prices and international demand drove activity, with the Permian and Eagle Ford basins being key areas of focus.